On July 3, 2025, analyst Robert Burns from HC Wainwright & Co. reiterated a "Buy" rating for Replimune Group (REPL, Financial). The analyst maintained the price target at $22.00 USD, consistent with the previous assessment.
This reaffirmation indicates continued confidence in Replimune Group's potential performance in the stock market. The target price suggests a positive outlook for the company's stock, reflecting stability and potential growth opportunities.
Investors interested in Replimune Group (REPL, Financial) should note the maintained price target and buy rating as a signal of the company's expected market value, as assessed by HC Wainwright & Co.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 7 analysts, the average target price for Replimune Group Inc (REPL, Financial) is $22.71 with a high estimate of $31.00 and a low estimate of $17.00. The average target implies an upside of 137.85% from the current price of $9.55. More detailed estimate data can be found on the Replimune Group Inc (REPL) Forecast page.
Based on the consensus recommendation from 9 brokerage firms, Replimune Group Inc's (REPL, Financial) average brokerage recommendation is currently 1.7, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
